Your point is a very good one, and this is the fear that a lot of CARP members have. We don't want to reach minimum standards in terms of national pharmacare. We stand strongly behind patient choice and a variety of medications.
I'd like to highlight one of the examples I brought forward in my presentation. A person who lives with Crohn's disease or colitis, for example, does well on a biologic for several years. It's not a lifelong biologic, so when a person develops antibodies to that particular drug, they need to move on to the next level of biologic. So choice is very important for people who are taking medications.